New oral cancer drug targets immune system in advanced tumors
Disease control
Recruiting now
This early-stage study is testing a new oral medication called GIM-531 for people with advanced solid tumors that have stopped responding to standard treatments. The research will evaluate the drug's safety and effectiveness when taken alone and when combined with an existing imm…
Phase: PHASE1, PHASE2 • Sponsor: Georgiamune Inc • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC